Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
6.68
+0.37 (5.78%)
Apr 14, 2026, 3:52 PM EDT - Market open
Personalis Market Cap
Personalis has a market cap or net worth of $698.72 million as of April 14, 2026. Its market cap has increased by 121.13% in one year.
Market Cap
698.72M
Enterprise Value
464.58M
1-Year Change
121.13%
Ranking
Category
Stock Price
$6.68
Market Cap Chart
Since June 20, 2019, Personalis's market cap has decreased from $847.61M to $698.72M, a decrease of -17.57%. That is a compound annual growth rate of -2.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 660.52M | -6.56% |
| Dec 31, 2025 | 706.88M | 72.20% |
| Dec 31, 2024 | 410.49M | 298.67% |
| Dec 29, 2023 | 102.97M | 13.12% |
| Dec 30, 2022 | 91.02M | -85.76% |
| Dec 31, 2021 | 639.07M | -55.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veracyte | 2.47B |
| GRAIL | 1.87B |
| GeneDx Holdings | 1.75B |
| NeoGenomics | 1.00B |
| OPKO Health | 880.52M |
| CareDx | 822.02M |
| Castle Biosciences | 687.68M |
| Fulgent Genetics | 416.23M |